Find Clinical Trial

Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction. A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study

← Back
Study Phase

Phase 2

Therapeutic Area

Cardiovascular Diseases

IndicationHeart failure
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device


Active Substance CodeS038844
Protocol CodeCL2-38844-010
EudraCT Code2013-003000-39

Documents and links

Results summary READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.